0001104659-23-086955.txt : 20230802 0001104659-23-086955.hdr.sgml : 20230802 20230802213254 ACCESSION NUMBER: 0001104659-23-086955 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230731 FILED AS OF DATE: 20230802 DATE AS OF CHANGE: 20230802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koziel Margaret CENTRAL INDEX KEY: 0001898760 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 231137756 MAIL ADDRESS: STREET 1: C/O AXCELLA HEALTH INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 tm2322589-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-07-31 0 0001080014 Innoviva, Inc. INVA 0001898760 Koziel Margaret 1350 OLD BAYSHORE HIGHWAY, SUITE 400 BURLINGAME CA 94010 0 1 0 0 Chief Medical Officer 0 Nonqualified Stock Option 13.55 2023-07-31 4 A 0 60000 0 A 2024-07-31 2033-07-31 Common Stock 60000 60000 D 25% of the options will vest on July 31, 2024 and the balance will vest in twelve (12) substantially equal installments thereafter on each three (3) month anniversary of the initial vesting date, in each case, subject to Dr. Koziel's continuous service through the applicable vesting date, with accelerated vesting (i) in the event of a "change in control" (as defined in the Issuer's 2012 Equity Incentive Plan) in which the options are not assumed or replaced, or (ii) in the event that Dr. Koziel experiences a termination of employment by the Innoviva, Inc. without "cause" or by Dr. Kozial for "good reason" (each as defined in Dr. Koziel's employment agreement) within 12 months following a "change in control.," subject to an effective release of claims. /s/ Margaret Koziel 2023-08-02